ARCHIVES

Triple-Negative Breast Cancer Equally Aggressive in Whites

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Centocor Withdraws Yondelis After FDA Calls for New Study

April 29, 2011

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

In Brief: Karen Antman And John Glick lead ASCO; ODAC to Meet June 7 On Tamoxifin Trial

May 27, 1994

GAO Report On NCI Cancer Control Contracts (Continued)

August 1, 1980

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991

In Brief: Switch To Grants Did Not hurt Virus Research, Watson says; The Field Is Healthy, Well Funded

October 2, 1981